|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
|
|---|---|---|---|
| Cash Flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Non-cash interest expense | |||
| Loss on extinguishment of convertible debentures | |||
| Gain on extinguishment of debt | |||
| Change in fair value of warrant liabilities | |||
| Change in fair value of convertible debenture embedded derivative liabilities | |||
| Change in fair value of convertible debentures | |||
| Non-cash lease expense | |||
| Foreign currency adjustments | |||
| Amortization of premium/discount on marketable securities | |||
| Loss on the disposal of property and equipment | |||
| Debt issuance costs expensed upon issuance of convertible debentures recorded using the fair value option | |||
| Net amortization of premiums (accretion of discounts) on marketable securities | |||
| Unrealized foreign currency losses (gains) | |||
| Share-based compensation expense | |||
| Depreciation of property and equipment | |||
| Changes in operating assets and liabilities: | |||
| Investment tax credit receivable | |||
| Prepaid expenses and other assets | |||
| Accounts payable | |||
| Accrued expenses and other current liabilities | |||
| Lease liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Purchases of property and equipment | |||
| Purchases of investments | |||
| Purchases of marketable securities | |||
| Proceeds from maturities of marketable securities | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities | |||
| Payment of Reverse Recapitalization and PIPE Financing costs | |||
| Proceeds from issuance of April 2023 Notes | |||
| Payment of issuance costs associated with April 2023 Notes | |||
| Repayment of convertible debentures | |||
| Proceeds from the February 2024 PIPE Financing | |||
| Payments of issuance costs associated with the 2024 PIPE Financing | |||
| Proceeds from FEAC trust account in connection with Reverse Recapitalization | |||
| Payment of transaction costs in connection with the Reverse Recapitalization and PIPE Financing | |||
| Proceeds from exercise of common share warrants | |||
| Proceeds from exercise of stock options | |||
| Repayments of term loan principal | |||
| Proceeds from issuance of term loan | |||
| Payments of debt issuance costs associated with the term loan | |||
| Net cash provided by financing activities | |||
| Effect of exchange rate changes on cash | |||
| Net (decrease) increase in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of period | |||
| Cash and cash equivalents at end of period | |||
| Supplemental cash flow information: | |||
| Cash paid for interest | |||
| Supplemental disclosure of non-cash investing and financing activities | |||
| Reverse Recapitalization and PIPE financing transaction costs included within accrued expenses | |||
| Conversion of Preferred Shares upon Reverse Recapitalization | |||
| Warrant value issued as part of Amended Term Loan | |||
| Conversion of Convertible Debentures upon Reverse Recapitalization | |||
| Reclassification of warrant liability to equity upon Reverse Recapitalization | |||
| Liabilities assumed upon Reverse Recapitalization | |||
| Warrant liability recognized upon issuance of term loan | |||
| Settlement of derivative liability upon repayment and conversion of convertible debentures | |||
| Right of use assets obtained in exchange for lease liabilities | |||
| Property and equipment included in accrued expenses and accounts payable | |||
| Settlement of April 2023 Notes through the issuance of May 2023 Notes and warrants |
Loading...